Top News

  • NCAA and DOD expand concussion study with $22.5 million in new funding

    The world’s most comprehensive concussion study is being dramatically expanded with an infusion of nearly $22.5 million in new funding from the U.S. Department of Defense (DOD) and the National Collegiate Athletic Association (NCAA) to examine the impacts of head injuries over several years.

    The NCAA-DOD Concussion Assessment, Research and Education Consortium, known as the CARE Consortium, was established as part of the broader NCAA-DOD Grand Alliance in 2014, with the goals of understanding how concussions affect the brain and identifying ways to improve diagnosis, treatment and prevention.

    Led by Indiana University School of Medicine, the University of Michigan and the Medical College of Wisconsin, in collaboration with the Uniformed Services University, the study has collected data on more than 39,000 student-athletes and cadets at 30 colleges and military service academies--including more than 3,300 who have experienced concussions. This represents the largest sample of concussions ever researched in a single study.

    The initial phase of the study--made possible by a joint NCAA-Department of Defense grant of $30 million--focused on the acute effects of concussions by evaluating concussed participants with a sequence of clinical and advanced research tests in the immediate hours, days and weeks after the injury, and comparing the results with baseline tests administered at the start of the study.

    The new phase will include comprehensive testing of the participants when they leave college and up to four years after their collegiate sports or service academy career has ended. This expanded approach will enable researchers to study the intermediate and cumulative effects of concussion and repetitive head impact exposure. Importantly, researchers hope to differentiate between the effects of concussion, repetitive head impact and sports participation with no history of either concussion or repetitive head impact exposure.

    For more on the groundbreaking study, read the full news release.

    Back to Top ▲

  • Turrentine and Brown honored with Sagamore of the Wabash award

    Mark Turrentine, MD, John W. Brown Professor of Cardiothoracic Surgery, and John Brown, MD, Harris B Shumacker Professor Emeritus of Surgery, received Indiana’s highest civilian honor, the Sagamore of the Wabash award, during a surprise ceremony last week at Riley Hospital for Children at IU Health.

    Turrentine has been a Riley surgeon for almost 30 years, leading more than 20 global mission trips, helping more than 400 kids get heart surgery in other countries. Brown has served Riley and IU School of Medicine for 40 years and has operated on about 15,000 children.

    The pair has “worked together for decades.” “It was clear when Mark arrived on the scene some 30 years ago that he obviously had special dedication for the kind of work that we do,” Brown said. Turrentine added, “we’ve been partners for 30 years. It is a relationship I can’t even begin to tell you. It was just a very good professional marriage.”

    RTV6 news covered last week’s award ceremony.

    Back to Top ▲

  • IU Precision Health Initiative enables partner IU Health to administer CAR T-cell therapy to first pediatric patient

    Physicians at Riley Hospital for Children at Indiana University Health recently administered CAR T-cell therapy, a new type of cancer treatment, to the first pediatric patient to receive it in the state—one of the latest milestones enabled by Indiana University’s Precision Health Initiative.

    CAR T-cell therapy harnesses the disease-fighting power of a patient's own immune T-cells by taking them out of the patient's blood, changing them in a laboratory, then infusing them back into a patient's body to attack cancer cells.

    Learn more about this groundbreaking therapy and the first patient at Riley at IU Health to receive it.

    “Things are going well so far for our patient, and we already have seven more pediatric patients in the process of collection and manufacturing [for administration of CAR T-cell therapy], said Jodi Skiles, MD, assistant professor of clinical pediatrics at IU School of Medicine and director of pediatric stem cell transplant at Riley Hospital for Children at IU Health.

    As a result of the Precision Health Initiative, IU Health is the only approved site in Indiana to administer FDA-approved CAR T-cell therapies—widely considered by many to provide a significant curative option for certain types of difficult-to-treat leukemia and lymphomas.

    Back to Top ▲

  • What you need to know about paid time off to vote on November 6

    Voting in next Tuesday’s mid-term election? Indiana University policy allows paid time off for staff employees (up to a maximum of two hours) whose work schedules prevent them from voting between 6 am and 6 pm. (See this article for examples of when paid time off is allowed.)

    Check out IU School of Medicine’s Instagram page for photos of medical students exercising their right to vote last weekend.

    Contact Human Resources with questions about IU’s voting policy.


    Back to Top ▲

  • New “self, friends and family” patient record rules go into effect today

    Beginning Thursday, November 1, the Indiana University Health Privacy Office has activated a new security feature to detect “self, friends and family” access to patient health records. This new feature is a part of Haystack--a tool launched in February 2018 as an added safeguard to help keep patient information confidential and secure through tracking EMR activity.

    “Self, friends and family” access means viewing your own medical record or the medical record of someone you know without an authorized need and is one of the most common violations of patient privacy. It can harm the authenticity of important patient information and interfere with your ability, or the ability of your friend or family member, to receive the best care.

    Even if you’re acting with the best intentions, using Cerner, Epic, PACS or any kind of electronic medical record (EMR) system to view patient information without an authorized need is a violation of HIPAA laws and must be reported. If Haystack flags out-of-ordinary behaviors based on users’ previous activities, job codes and other factors, the Privacy Office is alerted to investigate.

    Refer to MEDNet for more details and information about patient privacy.

    Back to Top ▲

  • Take note of INScope’s year-end schedule

    INScope will alter its publication schedule during the holiday season. This month, the e-newsletter will not be distributed on Thanksgiving Day, Thursday, November 22. Publication will resume Thursday, November 29. The last 2018 issue of INScope will be published on Thursday, December 20, with the first issue of 2019 distributed on Thursday, January 10.

    Submit news items for the remaining 2018 issues as soon as possible to INScope editorial guidelines are available on MEDNet.


    Back to Top ▲

  • Flu shot deadline is next week

    The mandatory flu shot deadline is just one week away. As a reminder, all IU School of Medicine faculty, house staff and students who provide clinical care at Indiana University Health or Eskenazi Health, perform clinical research at these facilities or whose primary office is in an IU Health or Eskenazi Health hospital are required to receive a flu vaccination by Thursday, November 8.

    On the IUPUI campus, free flu shots are available at Campus Health (Coleman Hall, Suite 100). Students (only) also may obtain a flu shot at Campus Center Student Health. Free flu vaccinations are also available for IU School of Medicine staff.

    Flu vaccination information for other IU campuses is also available. 

    Back to Top ▲

Research News

  • Whac-A-Mole inspires new treatment for aggressive type of breast cancer

    Ever stop by an arcade? If you did, you almost certainly played Whac-A-Mole, the popular game in which toy rodents randomly pop up from holes, and you desperately try to thump them back into hiding with a mallet.

    For most, Whac-A-Mole was a fun way to pass time and maybe win some cheap arcade prizes. For Milan Radovich, PhD, and his team, it may be the answer to helping more individuals overcome triple negative breast cancer--a particularly aggressive form of the disease that disproportionately affects young women and African American women.

    Triple negative breast cancer is smart. Researchers will detect a potential genetic culprit they believe is helping the cancer grow. But when they knock it down with a drug, another misfit pops up, allowing the cancer to continue thriving.

    “It’s just like Whac-A-Mole,” thought Radovich, an assistant professor of surgery at Indiana University School of Medicine.

    But what if we could knock out the first “mole,” and predict which one would pop up next, he wondered. And what if we could block that hole, too? Would that be enough to short-circuit the game? Or, in his case, would that enable him to outsmart triple negative breast cancer and give cancer-fighting drugs a chance to do their job?

    His lab is about to find out, with the National Institutes of Health funding a study to test a new drug combination for triple negative breast cancer. Learn more in this Breast Cancer Research blog post.

    Back to Top ▲

  • IU researchers enrolling women in nationwide breast imaging study

    Indiana University School of Medicine radiology researchers will recruit 3,000 women to participate in TMIST, a nationwide study comparing the two most common technologies used for breast cancer screening.

    Tomosynthesis, also known as three-dimensional or 3-D mammography screening, will be compared with 2-D or conventional mammography in a study conducted by the National Cancer Institute and the ECOG-ACRIN Cancer Research Group. In total, the study will enroll 165,000 women over the next three years to determine which screening tool is best at identifying life-threatening cancers of the breast.

    Steven Westphal, MD, assistant professor of clinical radiology and imaging sciences, is the local principal investigator for TMIST at Indiana University, one of the first sites to begin enrolling patients in this study. The number of sites will grow to nearly 100 mammography clinics in the United States and Canada.

    Once enrolled, women will be assigned at random to either 2-D or 3-D mammography. Most women enrolled will be screened annually. Some postmenopausal women with no high-risk factors for breast cancer will be screened every two years. Women may also volunteer to give a blood sample and a mouth rinse for DNA to be included in a biorepository for future research on genetic markers for breast cancer.

    Learn more in the IU School of Medicine Newsroom.

    Back to Top ▲

Faculty and Staff News

  • Fallon approved for emeritus status

    Robert Fallon, MD, PhD, has been approved for the emeritus title of Zachary E. Klingler Professor of Pediatrics. Joining IU School of Medicine in August 2000, Fallon led the pediatric hematology/oncology group until 2016 and then transitioned into the role of outpatient medical director until 2017.

    A quintessential clinician, educator and leader, Fallon oversees key division activities, while also providing outstanding and consistent patient care and hands-on teaching for medical students and house staff. He continues to serve as a senior leader within the division. Additionally, he has served as an active member of the IU Simon Cancer Center Scientific Review Committee and the Department of Pediatrics promotions committee among other key roles. Fallon is respected by students, faculty and staff. He will retire from IU School of Medicine on November 2, 2018.

    Emeritus designation may be awarded upon retirement from IUPUI to faculty members and others as recognition of "substantial contributions to the university in the fields of teaching, research and/or service." Fallon’s emeritus status was approved by IUPUI Executive Vice Chancellor and Chief Academic Officer Kathy Johnson. IU School of Medicine congratulates Fallon and appreciates his contributions to the school and university.


    Back to Top ▲

  • Pratt to serve as president of the Association of Medical Pathology

    Victoria Pratt, PhD, associate professor of clinical medical & molecular genetics, has been elected president of the Association of Molecular Pathology. Her one-year term begins this month. Founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics, AMP has more than 2,400 members, including professionals from academic and community medical centers, government and industry.

    Back to Top ▲


  • Research equipment funding available for Bloomington faculty

    The Indiana CTSI (Bloomington) Research Equipment Program supports purchase of commercially available research equipment to be used by groups of investigators, working together or separately, on innovative projects to enhance externally funded research and the mission of the Indiana CTSI. An applicant must be an IU Bloomington faculty member, but applicants may include interested researchers at CTSI partner institutions. 

    Applications are due Friday, February 1, 2019.

    Back to Top ▲

  • Apply for the Translational Health Public Research Award

    Applications are now being accepted for projects focusing on any aspect of public health that ultimately leads to the improvement of human health outcomes. With the Translational Health Public Research Award, the goal of the IU School of Public Health-Bloomington is to provide a more holistic model for the field of public health so that the individual, social, environmental and policy factors that support optimal health and wellness have a viable framework from which to approach current human health conditions.

    Deadline to apply is Monday, February 4, 2019. Applications require a partnership between an IU Bloomington faculty member and a public health liaison and/or collaborator at another Indiana CTSI partner institution.

    Back to Top ▲

  • Check out medical library classes offered throughout November

    The Ruth Lilly Medical Library offers classes for faculty, staff and students. The November schedule includes these offerings:

    Determining Your Impact
    This class provides information on various metrics such as impact factors, Eigenfactors, the Becker Model and H-Indices. Attendees receive hands-on experience with using library resources to discover more information about tracking impact.

    EndNote Basics
    EndNote is a citation management software program allowing users to import citations from numerous literature databases into one spot. Users can then edit citations, add notes, import full text documents and use the program to format citations for articles, papers, grant proposals, etc.

    Mobile Resources
    This class provides information on the mobile resources available through the library, how to install and register these apps, and basic instructions on using these apps. The Mobile Resources guide also is discussed, including details on how to find other apps not available through the library. Attendees also will learn basic information about how to evaluate apps in app stores.

    Class dates and registration are available. All classes can be streamed live via Zoom.

    Back to Top ▲

  • Bloomington staff member is featured storyteller at event this Saturday

    David Matlack, BA, DVM, director of the physiology laboratory at IU School of Medicine-Bloomington, will be the featured storyteller at a Storytelling Arts of Indiana event from 7-8 pm, Saturday, November 3. The event will be held at the Eugene and Mary Glick Indiana History Center, 450 West Ohio St., in downtown Indianapolis. Matlack’s piece is titled “The Stories in Our Stones.” Visit for details and ticket information.

    Back to Top ▲

Partner News